135 related articles for article (PubMed ID: 12957244)
1. Cosmesis from the patient's and the doctor's view.
Hoeller U; Kuhlmey A; Bajrovic A; Grader K; Berger J; Tribius S; Fehlauer F; Alberti W
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):345-54. PubMed ID: 12957244
[TBL] [Abstract][Full Text] [Related]
2. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
[TBL] [Abstract][Full Text] [Related]
3. Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' views.
Toledano AH; Bollet MA; Fourquet A; Azria D; Gligorov J; Garaud P; Serin D; Bosset JF; Miny-Buffet J; Favre A; LeFoch O; Calais G
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):66-72. PubMed ID: 17448869
[TBL] [Abstract][Full Text] [Related]
4. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
5. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
[TBL] [Abstract][Full Text] [Related]
6. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores.
Hoeller U; Tribius S; Kuhlmey A; Grader K; Fehlauer F; Alberti W
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1013-8. PubMed ID: 12605981
[TBL] [Abstract][Full Text] [Related]
7. [Cosmetic results after breast conserving carcinoma treatment in patients with intramammarian seromas].
Schultze J; Lössl K; Kimmig B
Rontgenpraxis; 2008; 56(5):169-80. PubMed ID: 19294874
[TBL] [Abstract][Full Text] [Related]
8. Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis.
Dong Y; Li T; Churilla TM; Shaikh T; Sigurdson ER; Bleicher RJ; Weiss SE; Hayes SB; Anderson PR
Breast Cancer Res Treat; 2017 Dec; 166(3):787-791. PubMed ID: 28825145
[TBL] [Abstract][Full Text] [Related]
9. Cosmetic outcomes and complications reported by patients having undergone breast-conserving treatment.
Hill-Kayser CE; Vachani C; Hampshire MK; Di Lullo GA; Metz JM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):839-44. PubMed ID: 22137022
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a gold standard for cosmetic evaluation after breast conserving therapy: Results from the St George and Wollongong Breast Boost trial.
Merie R; Browne L; Cardoso JS; Cardoso MJ; Chin Y; Clark C; Graham P; Szwajcer A; Hau E
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):819-825. PubMed ID: 28834326
[TBL] [Abstract][Full Text] [Related]
11. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Study of Cosmetic Outcomes for Patients Treated with Breast Conservation and Radiation Therapy using Shorter Fractionation Schedules at Auckland Hospital, New Zealand.
Campbell G; Pearse M; Frampton C
Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):221-227. PubMed ID: 31740191
[TBL] [Abstract][Full Text] [Related]
13. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system.
Fehlauer F; Tribius S; Höller U; Rades D; Kuhlmey A; Bajrovic A; Alberti W
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):651-8. PubMed ID: 12573752
[TBL] [Abstract][Full Text] [Related]
14. Does the patient's opinion differ from the clinicians' regarding breast cosmesis after BCT?
Parmar V; Nadkarni MS; Kakade A; Hawaldar R; Badwe RA
Breast J; 2010; 16(1):103-4. PubMed ID: 19929893
[No Abstract] [Full Text] [Related]
15. Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors.
Hille-Betz U; Vaske B; Bremer M; Soergel P; Kundu S; Klapdor R; Hillemanns P; Henkenberens C
Strahlenther Onkol; 2016 Jan; 192(1):8-16. PubMed ID: 26416291
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy.
Perrucci E; Lancellotta V; Bini V; Falcinelli L; Farneti A; Margaritelli M; Capezzali G; Palumbo I; Aristei C
Tumori; 2015; 101(2):161-7. PubMed ID: 25768319
[TBL] [Abstract][Full Text] [Related]
18. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
19. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
20. Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer.
Rahimi A; Morgan HE; Kim DW; Zhang Y; Leitch M; Wooldridge R; Goudreau S; Haley B; Rao R; Rivers A; Spangler AE; Jones RT; Stevenson S; Staley J; Albuquerque K; Ahn C; Neufeld S; Alluri PG; Ding C; Garwood D; Seiler S; Zhao B; Gu X; Timmerman R
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):772-782. PubMed ID: 33476737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
